Journey Medical CFO resigns; Corporate Controller Benesch named interim CFO effective Jan 27.

Journey Medical Corp

Ernest De Paolantonio resigns as CFO effective Jan 27, 2023; will consult through March 31, 2023.
Joseph Benesch, Corporate Controller since Nov 2021, appointed interim CFO effective Jan 27, 2023.
Benesch has over 25 years of finance experience, is a CPA, and previously held senior roles at Teligent and Torrent.
No immediate change to Benesch's compensation; search for permanent CFO underway internally and externally.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Ernest De Paolantonio

Chief Financial Officer

DERM · Journey Medical Corp

Effective: 2023-01-27
Successor: Joseph Benesch
Filed: January 20, 2023, 6:59 PM ET

On January 16, 2023, Ernest De Paolantonio, the Chief Financial Officer of Journey Medical Corporation (the “ Company ”) provided notice to the Company of his resignation, effective January 27, 2023.

Appointed (interim)

Joseph Benesch

interim Chief Financial Officer

DERM · Journey Medical Corp

Effective: 2023-01-27
Filed: January 20, 2023, 6:59 PM ET

Joseph Benesch, age 56, the Company’s Corporate Controller, was appointed as the Company’s interim Chief Financial Officer, effective January 27, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Ernest De Paolantonio resigned as Chief Financial Officer at Journey Medical Corp.

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

On January 16, 2023, Ernest De Paolantonio, the Chief Financial Officer of Journey Medical Corporation (the “ Company ”) provided notice to the Company of his resignation, effective January 27, 2023.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Joseph Benesch was appointed as interim Chief Financial Officer at Journey Medical Corp.

Action: appointed
Role: interim Chief Financial Officer

Exact text from the filing

Joseph Benesch, age 56, the Company’s Corporate Controller, was appointed as the Company’s interim Chief Financial Officer, effective January 27, 2023.

View on SEC.gov

Journey Medical Corp filing history →

Source: SEC EDGAR

accession 0001104659-23-005408

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.